ReviewFrontiers in endocrinology2026
Insulin resistance, aging biology, and non- communicable chronic diseases: a narrative review of bidirectional mechanisms and translational implications.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insulin resistance has been considered a metabolic disorder related to obesity, metabolic syndrome, and type 2 diabetes mellitus. Growing evidence points to possible interactions between insulin resistance and hyperinsulinemia and the biological aging process and age-related non-communicable diseases, like cardiovascular disease, neurodegenerative disorders, sarcopenia, frailty, adipose tissue dysfunction, chronic kidney disease, and liver disease. Most published associations lack causality, and some biological aging mechanisms may also independently increase the risk for both insulin resistance and chronic disease. Aim: In this narrative review, we summarize bidirectional connections between insulin resistance, compensatory hyperinsulinemia, aging biology, and age-related non-communicable diseases and the quality of existing data. Methods: We performed a structured narrative literature review for mechanistic, translational, omics, epidemiologic, and intervention studies on the connection between insulin resistance and biological mechanisms of aging and chronic disease. Results: Mechanisms of age-related disease that may be affected by insulin resistance include insulin/IGF-1 signaling disruption, hyperinsulinemia, mitochondria dysfunction, oxidative stress, endothelial dysfunction, adipokine imbalance, chronic low-grade inflammation, cell senescence, ectopic lipids accumulation, AGE-RAGE signaling, and autophagy impairment. Aging mechanisms, such as cell senescence, mitochondria dysfunction, inflammaging, altered nutrient sensing, impaired proteostasis, adipose tissue remodeling, and physical inactivity may contribute to insulin resistance. Quality of evidence differs from strong to associative and exploratory depending on disease domain. Conclusion: It is important to understand insulin resistance as an important mediator in reciprocal network of connections between metabolism, biological aging, and age-related chronic diseases, rather than one of the causes of aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.